发明名称 UREA DERIVATIVE
摘要 <p>A urea derivative having excellent DGAT inhibitory activity or a pharmacologically acceptable salt thereof. The urea derivative is represented by the general formula (I) (II) (III) (XXXIX) (XL) [wherein R&lt;SUP&gt;1&lt;/SUP&gt; is, e.g., C&lt;SUB&gt;6-10 &lt;/SUB&gt;aryl optionally substituted independently by one to five groups selected from substituent groups (a); R&lt;SUP&gt;2&lt;/SUP&gt; is, e.g., C&lt;SUB&gt;6-10&lt;/SUB&gt; aryl optionally substituted independently by one to five groups selected from substituent groups (a); E is, e.g., a group having the formula (II) or (III) (wherein R&lt;SUP&gt;3&lt;/SUP&gt; is hydrogen, etc.; R&lt;SUP&gt;4&lt;/SUP&gt; and R&lt;SUP&gt;5&lt;/SUP&gt; are the same or different and each is hydrogen, etc.; X and U are the same or different and each is CH, etc.; and m and n are the same or different and each is 1, etc.); and A is -NH-C(=O)-, etc.].</p>
申请公布号 WO2006004200(A1) 申请公布日期 2006.01.12
申请号 WO2005JP12635 申请日期 2005.07.01
申请人 SANKYO COMPANY, LIMITED;KURATA, HITOSHI;UTO, YOSHIKAZU;FUJIBAYASHI, YUKO;KOHAMA, TAKAFUMI;TANIMOTO, TATSUO;KARASAWA, HIROSHI 发明人 KURATA, HITOSHI;UTO, YOSHIKAZU;FUJIBAYASHI, YUKO;KOHAMA, TAKAFUMI;TANIMOTO, TATSUO;KARASAWA, HIROSHI
分类号 (IPC1-7):C07D211/62;A61P15/08;A61P13/12;A61P11/00;A61P9/12;A61P9/10;A61P9/00;A61P3/10;A61P3/06;A61P3/04;A61P1/16;A61K31/551;A61K31/496;A61K31/495;A61K31/472;A61K31/451;A61K31/444;A61K31/443;C07D417/12;C07D405/12;C07D401/14;C07D401/12;C07D295/20;C07D295/18;C07D295/12;C07D243/08;C07D241/04;C07D217/06;C07D213/76;C07D213/75;C07D211/60;A61P43/00;A61P27/12;A61P27/02;A61P25/02;A61P21/00;A61P19/06;A61P19/02 主分类号 (IPC1-7):C07D211/62
代理机构 代理人
主权项
地址
您可能感兴趣的专利